Collagen peptides: protein, minced
Take collagen — the structural protein from animal or fish skin and connective tissue — and split it with enzymes into thousands of short fragments of varying length. The resulting hydrolysate is what gets sold as "collagen peptides". It's not one molecule but a statistical mixture, and its composition drifts batch to batch.
It's a legal food product with its own clinical literature — for example, the 2014 double-blind, placebo-controlled study by Proksch and colleagues on skin parameters. You can argue about effect sizes, but the genre of evidence is dietary: a supplement eaten off a spoon.
A research peptide: one molecule, built to blueprint
A research compound is the opposite genre. One sequence, assembled by a synthesiser link by link, with identity and purity documentation for the specific batch. Not a mixture — a molecule. Not "roughly this composition" — an exact formula.
The regulation is opposite too: it's neither food nor medicine but a laboratory reagent — not for human use. The quality questions differ accordingly: not "how many grams per serving" but "does the mass match the calculation and what did the chromatogram show".
Why keeping them apart matters
Marketing loves gluing categories together: "peptide" sells, so everything gets the label. But evidence doesn't transfer between categories. A study of collagen powder says nothing about a synthetic compound, and vice versa. Whenever you read about "peptides", the first question is which of the two worlds is being discussed.
References
- Oral supplementation of specific collagen peptides has beneficial effects on human skin physiology: a double-blind, placebo-controlled study — Skin Pharmacology and Physiology, 27(1), 47–55 (PMID 23949208; DOI 10.1159/000351376), 2014.
- Therapeutic peptides: Historical perspectives, current development trends, and future directions — Bioorganic & Medicinal Chemistry, 26(10), 2700–2707 (PMID 28720325; DOI 10.1016/j.bmc.2017.06.052), 2018.
